# OnCo record interception-vaccination (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/interception-vaccination/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "interception-vaccination" ;
  schema:name "Cancer interception vaccines"@en ;
  schema:description "Cancer interception vaccines immunise people who do not yet have cancer but carry a high inherited risk, such as Lynch syndrome carriers, against the antigens their future tumour is predicted to express, so memory T cells remove transformed cells early. Because healthy people accept risk for a probabilistic benefit, the safety bar is far higher and trials take years."@en ;
  schema:url <https://onco.cc/technologies/interception-vaccination/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?term=Lynch%20syndrome%20vaccine> ;
  onco:status "phase-2" ;
  onco:tag "frontier", "radical" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/tnbc/> ;
  onco:sections <https://onco.cc/fronts/prevention/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/>, <https://onco.cc/technologies/chemoprevention/>, <https://onco.cc/technologies/germline-testing/>, <https://onco.cc/technologies/hpv-vaccine/> ;
  onco:targets <https://onco.cc/targets/brca/> .